Reference
Shen X, et al. Detection and monitoring of driver mutations by next-generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR-tyrosine kinase inhibitors. Thoracic Cancer 9: 181-184, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12551 - China
Rights and permissions
About this article
Cite this article
Gefitinib. Reactions Weekly 1696, 172 (2018). https://doi.org/10.1007/s40278-018-44360-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44360-5